Metabolic and bariatric surgery may improve not only systemic metabolic health, but also the optical clarity of the cornea and crystalline lens, according to a new prospective study published in BMC Ophthalmology.
Researchers in Turkey reported significant reductions in both corneal densitometry (CD) and lens densitometry (LD) six months after laparoscopic sleeve gastrectomy (LSG), suggesting that substantial weight loss may influence ocular tissue transparency in previously underrecognized ways.
The study evaluated 58 eyes from 58 obese patients undergoing LSG, one of the most commonly performed metabolic surgeries worldwide. Using Pentacam HR Scheimpflug imaging, investigators measured changes in corneal and lens optical density before surgery and six months afterward. Densitometry values quantify light scatter within ocular tissues, with higher grayscale unit (GSU) values indicating reduced transparency.
Six months after surgery, mean body mass index fell from 43.4 kg/m² to 31.5 kg/m², accompanied by significant improvements in glucose and lipid parameters. But alongside these systemic changes, the eye itself appeared to undergo measurable structural and optical shifts.
Average corneal densitometry decreased from 15.2 to 12.9 GSU, while lens densitometry fell from 10.9 to 9.8 GSU. According to the study authors, these findings may reflect improved tissue transparency after metabolic normalization.
“The main finding of this study was that both CD and LD showed significant reductions six months after surgery, suggesting measurable changes in the optical density of ocular tissue following substantial metabolic weight loss,” the investigators wrote in their discussion.
The study also documented significant reductions in intraocular pressure and central corneal thickness after surgery, alongside increases in anterior chamber depth and angle. However, corneal curvature parameters remained stable, suggesting the observed changes were more closely related to tissue optical properties than gross structural reshaping.
Obesity has increasingly been linked to ocular pathology through mechanisms including oxidative stress, chronic inflammation, altered corneal biomechanics, and microvascular dysfunction. Previous studies have associated obesity with elevated intraocular pressure, small-fiber corneal nerve damage, and increased cataract risk.
The authors speculate that reductions in systemic oxidative stress and inflammatory burden after bariatric surgery may partly explain the densitometric improvements observed in both the cornea and lens. Interestingly, changes in corneal and lens densitometry showed a moderate positive correlation, suggesting parallel biological responses across ocular tissues.
Still, direct links between ocular changes and systemic metabolic markers were relatively weak. Lens densitometry showed only a modest association with fasting glucose reduction, while corneal densitometry did not correlate significantly with BMI or HbA1c changes. The researchers suggest local biochemical factors – including collagen organization, hydration, and oxidative stress responses – may play a larger role than global metabolic measures alone.
The authors caution that the clinical significance of the relatively small densitometry changes remains uncertain. The study was limited by its single-center design, modest sample size, and six-month follow-up period. Molecular markers of oxidative stress were also not evaluated.
Nevertheless, the findings suggest that improving systemic metabolism could subtly enhance ocular transparency before clinically visible disease develops.
